We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| Albert David Limited | 1023.26 | 153.04 | 899.27 | 26.81 | 443.0 | 70.5 |
| Bafna Pharmaceuticals Limited | 395.05 | 18.37 | 382.86 | 0.78 | 417 | 41.4 |
| Medicamen Biotech Limited | 474.43 | 16.35 | 469.08 | 1.21 | 412 | 43.4 |
Albert David Ltd.,, with Security Code 524075, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 89.4 | 98.4 | 83.1 | 74.9 | 70.6 | 87.2 | 89.9 | 89.9 |
| Expenses | 88.5 | 92.2 | 82.4 | 79.6 | 81.2 | 84.7 | 79.1 | 79.1 |
| Operating Profit | 0.9 | 6.2 | 0.7 | -4.7 | -10.7 | 2.5 | 10.8 | 10.8 |
| OPM % | 0.98% | 6.32% | 0.81% | -6.22% | -15.1% | 2.91% | 12.04% | 12.04% |
| Other Income | 23.1 | 20.6 | -9.0 | -5.1 | 22.0 | -2.1 | 12.4 | 12.4 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.6 | 0.8 | 0.9 | 0.9 |
| Depreciation | 1.8 | 1.7 | 1.7 | 1.8 | 2.4 | 2.2 | 2.4 | 2.4 |
| Profit before tax | 22.1 | 25.1 | -10.2 | -11.7 | 8.4 | -2.6 | 19.9 | 19.9 |
| Tax % | 14.6% | 28.1% | -7.6% | 0% | 5.9% | -27.9% | 23.1% | 23.1% |
| Net Profit | 18.8 | 18.1 | -9.4 | -10.3 | 7.9 | -3.3 | 15.3 | 15.3 |
| EPS in Rs | 33.02 | 31.67 | -16.45 | 0 | 13.91 | -5.79 | 26.81 | 26.81 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -2% |
| 3 Years: | -20% |
| TTM: | -77% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 15% |
| 1 Year: | -29% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|